Evidence map›Paper›PMID 40577029›Full record

Trial reportJournal of psychopharmacology (Oxford, England)2025

Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls - A randomized placebo-controlled crossover trial.

Johanna M Hoppe, Johannes Björkstrand, Johan Vegelius, Lisa Klevebrant, Malin Gingnell, Andreas Frick

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychopharmacology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Johanna M HoppeExperimental Cognitive and Affective Neuroscience Lab, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-1214-2586
Johannes BjörkstrandDepartment of Psychology, Lund University, Lund, Sweden.
Johan VegeliusExperimental Cognitive and Affective Neuroscience Lab, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-0497-0659
Lisa KlevebrantExperimental Cognitive and Affective Neuroscience Lab, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Malin GingnellExperimental Cognitive and Affective Neuroscience Lab, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Andreas FrickExperimental Cognitive and Affective Neuroscience Lab, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-2516-9075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCaffeine in doses above 400 mg, approximately four cups of coffee, induces panic attacks in 50% of individuals with panic disorder (PD) and elevates anxiety, but it is not known how individuals with PD respond to normally consumed doses or how caffeine interacts with emotional tasks.

aimsWe hypothesized that 150 mg caffeine would increase subjective anxiety (primary outcome) as well as interoceptive attention and anxiety from bodily signals in patients with PD, and more so than in healthy controls (HCs). Additional analyses targeted panic attacks, emotional reactivity, avoidance behavior, and subjective exteroceptive attention.

methodsTwenty-nine patients with PD and 53 HC with low habitual caffeine consumption (⩽300 mg/week) abstained from caffeine 36 h before receiving 150 mg caffeine or placebo in a double-blind randomized crossover design 2-14 days apart.

resultsContrary to our hypotheses, caffeine did not increase subjective anxiety, interoceptive attention, or anxiety from interoceptive signals. Only one panic attack was noted, in the PD group after caffeine intake during the emotional reactivity task. In both PD and HC, caffeine increased skin conductance responses to neutral and emotional faces, augmented costly avoidance behavior, and impaired exteroceptive attention. These results indicate that low caffeine doses do not have differential anxiogenic effects in patients with PD and HC at rest, and that they increase arousal and avoidance behavior in both PD and healthy individuals.

conclusionsIn conclusion, we suggest that recommendations for caffeine abstinence for patients with PD should be based on higher doses and ideally on individual assessments.

Indexed as

AnxietyCaffeineCentral Nervous System StimulantsPanic DisorderAdultAttentionCross-Over StudiesDouble-Blind MethodEmotionsFemaleGalvanic Skin ResponseHumansInteroceptionMaleMiddle AgedYoung AdultCaffeineCentral Nervous System StimulantsAnxietycaffeinepanic disorder

Identifiers

PMID40577029
PMCPMC12287556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.